Literature DB >> 9252653

Expression of CD44, ICAM-1 and N-CAM in colorectal cancer. Correlation with the tumor stage and the phenotypical characteristics of tumor-infiltrating lymphocytes.

S Wimmenauer1, H Keller, K D Rückauer, S Rahner, G Wolff-Vorbeck, G Kirste, S von Kleist, E H Farthman.   

Abstract

The cellular adhesion molecules (CAMs) CD44s, CD44v6, CD44v10, ICAM-1 and N-CAM were immunohistologically detected in colorectal cancers using the APAAP method. The expression of CD44s and CD44v6 was associated with the presence of lymph node metastases in the examined tumors. The pattern of ICAM-1 expression was inversely related to that of CD44, i.e. lower numbers of ICAM-1 positive cells were observed in metastasizing tumors. An intense focal staining of N-CAM was observed in the majority of the metastasizing tumors. The expression of CD44v, ICAM-1 or N-CAM on tumor cells did not correlate with the density of the tumor-infiltrating lymphocytes (TIL) within the tumors. The flowcytometric analysis of TIL showed a significant accumulation of CD25+ and HLA-DR+ cells and a reduced number of CD45RA+ cells as compared to autologous peripheral blood lymphocytes (PBL) or intraepithelial lymphocytes of the colon mucosa (IEL). These phenotypic characteristics of TIL did not correlate with the CAMexpression on tumor cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252653

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.

Authors:  Lili Wang; Qin Liu; Dongliang Lin; Maode Lai
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 2.  Role of LFA-1 and ICAM-1 in Cancer.

Authors:  Manuel Reina; Enric Espel
Journal:  Cancers (Basel)       Date:  2017-11-03       Impact factor: 6.639

3.  Actin stabilizer TAGLN2 potentiates adoptive T cell therapy by boosting the inside-out costimulation via lymphocyte function-associated antigen-1.

Authors:  Bu-Nam Jeon; Hye-Ran Kim; Yun Shin Chung; Bo-Ra Na; Hyunkyung Park; Chorong Hong; Yasmin Fatima; Hyeonju Oh; Chang-Hyun Kim; Chang-Duk Jun
Journal:  Oncoimmunology       Date:  2018-09-06       Impact factor: 8.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.